We are live on
!
Find out more
CI
Clal Insurance Portfolio holdings
AUM
$22.3B
1-Year Est. Return
79.91%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
+79.91%
3 Year Est. Return
+201.85%
5 Year Est. Return
+220.25%
10 Year Est. Return
+954.66%
AUM
$8.37B
AUM Growth
+$1.69B
(+25%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
45.78%
Holding
159
New
14
Increased
30
Reduced
35
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$1.03B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$188M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$104M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$81.6M |
| 5 |
Invesco NASDAQ 100 ETF
QQQM
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$147M |
| 2 |
Nutrien
NTR
|
+$147M |
| 3 |
Check Point Software Technologies
CHKP
|
+$89M |
| 4 |
Franklin FTSE Brazil ETF
FLBR
|
+$74.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$52.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.63% |
| 2 | Technology | 25.68% |
| 3 | Industrials | 7.5% |
| 4 | Communication Services | 7.04% |
| 5 | Healthcare | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Enphase Energy
ENPH
$4.7B
| $3.1M | 0.04% |
18,497
-67,039
| -78% | -$12M |
|
102
FIVE9
FIVN
$2.55B
| $3.03M | 0.04% |
36,738
| – | – |
|
103
ICL Group
ICL
$7.07B
| $2.86M | 0.03% |
+522,141
| New | +$3.16M |
|
104
Taboola.com
TBLA
$1.03B
| $2.68M | 0.03% |
861,376
-1,258,621
| -59% | -$3.45M |
|
|
TEAD
105
Teads Holding Co
TEAD
$45.2M
| $2.29M | 0.03% |
464,984
+210,879
| +83% | +$927K |
|
106
JFrog
FROG
$11.4B
| $2.22M | 0.03% |
80,000
| – | – |
|
107
iShares MSCI Emerging Markets ex China ETF
EMXC
$24.9B
| $1.99M | 0.02% |
38,290
| – | – |
|
108
Fiverr
FVRR
$322M
| $1.5M | 0.02% |
57,801
| – | – |
|
109
Sanofi
SNY
$102B
| $1.08M | 0.01% |
20,000
| – | – |
|
110
Intuitive Surgical
ISRG
$135B
| $1.03M | 0.01% |
3,000
-2,000
| -40% | -$605K |
|
111
Eli Lilly
LLY
$1.01T
| $938K | 0.01% |
2,000
-500
| -20% | -$210K |
|
112
Broadcom
AVGO
$1.62T
| $867K | 0.01% |
10,000
-5,000
| -33% | -$357K |
|
|
ATVI
113
DELISTED
Activision Blizzard
ATVI
| $843K | 0.01% |
+10,000
| New | +$809K |
|
114
State Street Utilities Select Sector SPDR ETF
XLU
$21.5B
| $720K | 0.01% |
22,000
| – | – |
|
115
Merck
MRK
$358B
| $692K | 0.01% |
6,000
+500
| +9% | +$56.8K |
|
116
Amgen
AMGN
$203B
| $666K | 0.01% |
3,000
-2,000
| -40% | -$464K |
|
117
US Global Jets ETF
JETS
$727M
| $621K | 0.01% |
29,000
| – | – |
|
118
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.95B
| $603K | 0.01% |
16,000
| – | – |
|
|
WBA
119
DELISTED
Walgreens Boots Alliance
WBA
| $570K | 0.01% |
20,000
-9,000
| -31% | -$293K |
|
120
Gilead Sciences
GILD
$183B
| $539K | 0.01% |
7,000
-3,000
| -30% | -$239K |
|
121
ASML
ASML
$615B
| $362K | ﹤0.01% |
+500
| New | +$340K |
|
122
iShares US Healthcare Providers ETF
IHF
$1.31B
| $288K | ﹤0.01% |
5,635
| – | – |
|
123
Accenture
ACN
$116B
| $278K | ﹤0.01% |
+900
| New | +$262K |
|
124
Ambarella
AMBA
$2.77B
| $251K | ﹤0.01% |
+3,000
| New | +$219K |
|
125
Arista Networks
ANET
$249B
| $243K | ﹤0.01% |
+6,000
| New | +$232K |
|
Similar funds
LF
DCP
CS
CIG
TAF
SOMRS
MIM
Clal Insurance's Q2 2023 Portfolio in Review
As of Q2 2023, Clal Insurance held 159 positions worth $8.37B, up 25% from $6.68B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Clal Insurance deployed $1.31B of net new capital in Q2 2023, opening 14 new positions and adding to 30 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 7,154,000 shares worth $1.07B.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Nutrien, an estimated $147M trimmed.
- Clal Insurance's largest Q2 2023 buy was Invesco S&P 500 Equal Weight ETF: 7,154,000 shares worth $1.07B.
- Clal Insurance added most to Teva Pharmaceutical Industries Limited in Q2 2023, an estimated $104M increase.
- Clal Insurance's biggest Q2 2023 reduction was Nutrien, cutting an estimated $147M.
- Clal Insurance fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $147M.
- Clal Insurance's ten largest holdings make up 46% of its $8.37B portfolio in Q2 2023.
- Clal Insurance opened 14 new positions and closed 11 in Q2 2023.
- Clal Insurance's portfolio value rose 25% quarter-over-quarter to $8.37B.
Based on Clal Insurance's 13F filing for Q2 2023, filed 7 Aug 2023.